Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
002800
vs
K
KOSPI 200
Over the past 12 months, Sinsin Pharmaceutical Co Ltd has underperformed KOSPI 200, delivering a return of -19% compared to KOSPI 200's +119% growth.
Stocks Performance
002800 vs KOSPI 200
Performance Gap
002800 vs KOSPI 200
Performance By Year
002800 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sinsin Pharmaceutical Co Ltd
Glance View
Sinsin Pharmaceutical Co Ltd is a South Korean drug maker that focuses on medicines for pain relief, inflammation, and related everyday ailments. It sells prescription drugs and over-the-counter products, with a strong emphasis on patch-style and topical treatments that are easy for patients to use. The company’s customers are hospitals, clinics, pharmacies, and consumers who buy its branded medicines through retail channels. The company makes money by developing, manufacturing, and selling pharmaceutical products under its own brands and through healthcare distribution channels. Its business depends on how well its products are trusted by doctors, pharmacists, and patients, since many of its medicines are used for common conditions where repeat buying and brand familiarity matter. That means sales are driven not just by the drug ingredients, but by the company’s ability to get products listed, prescribed, and stocked in pharmacies. What makes Sinsin Pharmaceutical’s role different is its focus on practical dosage forms such as patches and topical medicines rather than only traditional pills. This gives it a clear place in the healthcare value chain: it turns pharmaceutical ingredients into easy-to-use products that can be sold through clinics and pharmacies to everyday patients. For beginner investors, it helps to think of the company as a branded medicines business built around common treatments and convenient delivery formats.